Skip to main content
. 2019 Jul 17;11:178. doi: 10.3389/fnagi.2019.00178

Figure 9.

Figure 9

Effects of pioglitazone and Aβ1–42 on the binding of CDK5 to PPARγ in AD model neurons. (A) Representative immunoblots to show reciprocal co-IP experiments in using anti-CDK5 or anti-PPARγ antibodies. (B) Intergroup comparisons of CDK5 protein levels in immunoprecipitated complexes obtained using anti-PPARγ antibody. (C) Intergroup comparisons of PPARγ protein levels in immunoprecipitated complexes obtained using anti-CDK5 antibody. n = 6 wells per group. *P < 0.05 compared to the control group, #P < 0.05 compared to the Aβ group, °P < 0.05 compared to the Pio group.